Role of cell wall mutation in antimicrobial resistance in Escherichia
coli H7:O157
Abstract
The E. coli H7:O157 was the subject of many studies. It is
characterized by producing Shiga toxins, abdominal illness, and
developing resistance to antimicrobial agents. A total 20 fecal samples
tested positive for E. coli H7:O157 from patients showed the
typical symptoms of the infection, and another 20 from animals were
collected. The bacterium was isolated, identified, and classified using
culture medium, and molecular methods. Results obtained from
classification of E. coli H7:O157 showed it is highly similar to
E. coli H7:O157 strain Sakai. The genes rpoB, stx,
waa, and rfbO were deposited in the NCBI website under
accession no. PP059841, OR939814, PP059843, and PP059842 respectively.
The mutant sequences of waa sites K, L, Y were analyzed to
determine the shifting in their function, cell wall formation, and the
ability to develop antibiotic resistance the mutant E. coli
H7:O157 compared to the wild type. We found that the resistance to
antibiotics in mutant E. coli H7:O157 increased significantly
when compared to the wild type. Animals. The explanation for this may be
attributed to the waa K, and waa L by preventing theentry
of antimicrobial agents into the bacterial cell.